Issue

Vol. 30 No. 1 (2018): Vol 30 Issue 1

Copyright (c) 2018 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Design, Synthesis and Hydrolysis Study of Gatifloxacin-NSAIDs as Mutual Prodrugs

https://doi.org/10.14233/ajchem.2018.20981
Noor H. Naser
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Kufa, Kufa, Iraq

Corresponding Author(s) : Noor H. Naser

noorh.naser@uokufa.edu.iq; noorhatef@yahoo.com

Asian Journal of Chemistry, Vol. 30 No. 1 (2018): Vol 30 Issue 1

Abstract

Four different well-known non-steroidal anti-inflammatory drugs (naproxen, ketoprofen, diclofenac and ibuprofen) were linked to gatifloxacin anti-infective drug which possess anti-inflammatory activity, using chloroacetyl chloride as spacer, in order to synthesize a novel mutual prodrugs that give synergestic anti-inflammatory effect, in addition to temporary mask the carboxyl group of the non-steroidal drugs, which reduce the gastric ulceration and bleeding. The chemical structures of the synthesized compounds were confirmed and characterized using FT-IR spectroscopy, 1H NMR spectroscopy, elemental microanalysis, melting points and Rf values. in vitro hydrolysis study of the synthesized mutual prodrugs was performed at different pHs (1.2 and 7.4), which reveal the chemical stability of these compounds inside the gastrointestinal tract. While their hydrolysis in 80 % human plasma, was revealed rapid conversion of the four synthesized prodrugs inside blood circulation to give the parent drug molecules, with about 40-55 % hydrolysis occur in the first hour.

Keywords

Gatifloxacin Prodrugs Flouroquinolones Non-steroidal anti-inflammatory drugs
Naser, N. H. (2017). Design, Synthesis and Hydrolysis Study of Gatifloxacin-NSAIDs as Mutual Prodrugs. Asian Journal of Chemistry, 30(1), 195–200. https://doi.org/10.14233/ajchem.2018.20981
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. R.V. Ghadage, J. Biol. Scient. Opin., 1, 255 (2013); https://doi.org/10.7897/2321-6328.01327.
  2. A. Abu-jaish, S. Jumaa and R. Karaman, Prodrugs Overview, In: Prodrugs Design-A New Era, Nova Publisher, USA, pp. 7-102 (2014).
  3. B. Jolanta, Pharmacol. Rep., 65, 1 (2013); https://doi.org/10.1016/S1734-1140(13)71253-2.
  4. S. Shirke, S. Shewale and M. Satpute, Int. J. Pharm. Chem. Boil. Sci., 5, 232 (2015).
  5. N. Sharma,A.K. Sahdev and V. Raj, Org. Med. Chem. Int. J., 2, 1 (2017); https://doi.org/10.19080/OMCIJ.2017.02.555586.
  6. S. Ohlan, S. Nanda, D.P. Pathak and M. Jagia, Int. J. Scient. Sci. Res., 2, 719 (2011).
  7. S.S. Dhaneshwar, D. Bhosle, S. Bharambe and N. Gairola, Indian J. Pharm. Sci., 68, 286 (2006); https://doi.org/10.4103/0250-474X.26654.
  8. S. Ramakrishna, V. Mihira, K.R. Vyshnavi and V. Ranjith, Int. J. Curr. Pharm. Res., 4, 90 (2012).
  9. P. Datar and T. Shendge, Chem. Inform., 1, 1 (2015).
  10. I. Perkovic, Z.R. Dzolic and B. Zorc, Acta Pharm., 63, 409 (2013); https://doi.org/10.2478/acph-2013-0023.
  11. M.F. Mahdi, N.H. Naser and N.H. Hammud, Int. J. Pharm. Pharm. Sci., 9, 66 (2017); https://doi.org/10.22159/ijpps.2017v9i7.18273.
  12. M.F. Mahdi, A.-M.R. Raauf and N.M. Mohammed, Eur. J. Chem., 6, 461 (2015); https://doi.org/10.5155/eurjchem.6.4.461-467.1321.
  13. I.Q. Abdulla, Nat. Sci., 6, 47 (2014); https://doi.org/10.4236/ns.2014.62008.
  14. K. Dweib, S. Jumaa, A. Thawabteh, L. Scrano, S.A. Bufo, G. Mecca and R. Karaman, World J. Pharm. Pharmaceut. Sci., 4, 1960 (2015).
  15. S.L. Abdulhadi, A.J. Qasir and N.A. Abdul Razzak, Iraqi J. Pharm. Sci., 22, 22 (2013).
  16. M. Asif, Res. Rev.: J. Chem., 4, 28 (2015).
  17. S. Saleh, M. Mohammad, S.H. Mashallah, E. Elayeh, I. AlMasri, H.S. Al-Khatib, M. Fararjeh and Y. Bustanji, Sci. Res. Essays, 7, 310 (2012); https://doi.org/10.5897/SRE11.126.
  18. G. Sarkozy, Vet. Med.−Czech, 46, 257 (2001).
  19. V. Yadav, S. Sultana, J. Yadav and N. Saini, PLoS One, 7, e47796 (2012); https://doi.org/10.1371/journal.pone.0047796.
  20. M.H. Mohammed, M.F. Mahdi, N.H. Naser and S.M. Ali, J. Nat. Sci. Res., 5, 106 (2015).
  21. F. Shamsa, A. Foroumadi, H. Shamsa, N. Samadi, M.A. Faramarzi and A. Shafiee, Iran. J. Pharm. Res., 10, 225 (2011).
  22. T.J. Dougherty, A. Nayar, J.V. Newman, S. Hopkins, G.G. Stone, M. Johnstone, A.B. Shapiro, M. Cronin, F. Reck and D.E. Ehmann, Antimicrob. Agents Chemother., 58, 2657 (2014); https://doi.org/10.1128/AAC.02778-13.
  23. P.M. Hawkey, J. Antimicrob. Chemother., 51, 29 (2003); https://doi.org/10.1093/jac/dkg207.
  24. P.C. Sharma, A. Jain and S. Jain, Acta Polon. Pharm.-Drug Res., 66, 587 (2009).
  25. J. Xia, Y. Zhao, H.-H. Chen and J. Wang, Saudi Med. J., 34, 829 (2013).
  26. S.K. Raul, B. Shanmukha and D. Jhansi, Int. J. Pharm. Pharm. Sci., 7, 121 (2015).
  27. M. Zhao, B. Song and Y. Liu, Biomed. Res., 28, 3501 (2017).
  28. K. Soni, Indo Global J. Pharm. Sci., 2, 43 (2012).
  29. P. Yadav, P. Deolekar, V. Kanase and S. Mishra, Int. J. Pharm. Pharm. Sci. Res., 3, 2472 (2012).
  30. S.M. Uriarte, R.E. Molestina, R.D. Miller, J. Bernabo,A. Farinati, K. Eiguchi, J.A. Ramirez and J.T. Summersgill, Antimicrob. Agents Chemother., 48, 2538 (2004); https://doi.org/10.1128/AAC.48.7.2538-2543.2004.
  31. N. Sultana, M.S. Arayne, A. Naz and M.A. Mesaik, Chem. Cent. J., 7, 6 (2013); https://doi.org/10.1186/1752-153X-7-6.
  32. A. Kumar, Indian J. Pharm. Pharmacol., 2, 16 (2015).
  33. N. Madhavi and B. Lourdu Rani, Int. J. Pharma Bio Sci., 4, 951 (2013).
  34. N.A. Md Daud, M.Sc. Thesis, Novel Developments for Increased Efficacy and Longevity of Existing Clinicaly Approved Antibiotics. University of York, England (2012).
  35. A.K. Hussein, N.H. Nasser, A.H. Abdulsada and S.A. Hasan, Der Pharma Chemica, 8, 89 (2016).
  36. A.B. Talib, M.F. Mahdi and M.H. Mohammed, Int. J. Compreh. Pharm., 12, 1 (2010).
  37. V. Bharat, Der Pharma Chemica, 6, 347 (2014).
  38. R.M. Silverstein, F.X. Webster and D.J. Kiemle, Spectrometric Identification of Organic Compounds, John Wiley & Sons Inc., USA, edn 7, pp. 72-108 (2005).
  39. R.M. Silverstein, F.X. Webster and D.J. Kiemle, Spectrometric Identification of Organic Compounds, John Wiley & Sons Inc., USA, edn 7, pp. 144-2014 (2005).
  40. J. McMurry, Organic Chemistry, Thomson Learning Inc., USA, edn 7, pp/ 794-811 (2008).
  41. M.B. Smith and J. March, March Advanced Organic Chemistry, John Wiley & Sons Inc., New Jersey, USA, edn 6, pp. 425-656 (2007).
  42. M.A. Fox and J.K. Whitesell, Organic Chemistry, Jones and Barlett Publisher Inc., Canada, edn 3, pp. 376 (2004).
  43. D. Cairns, Essentials of Pharmaceutical Chemistry. T.J. International, Padstow, Cornwall, Great Britain, edn 3, pp. 59-79 (2008).
  44. J. McMurry, Organic Chemistry, Thomson Learning Inc., USA, edn 7, p. 808 (2008).
  45. B.A. Mechael, Kinetics of Product Stability, In: Pharmaceutics the Design and Manufacture of Medicines, Elsevier Limited: New York, NY, USA, edn 3, pp. 99-107 (2007).
  46. D.H. Jornada, G.F. dos Santos Fernandes, D.E. Chiba, T.R.F. de Melo, J.L. dos Santos and M.C. Chung, Molecules, 21, 42 (2016); https://doi.org/10.3390/molecules21010042.
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 1 Download : 0